6.XI.-((3S,5R)-3,5-DIHYDROXY-2-METHYLCYCLOHEX-1-EN-1-YL)-17.BETA.-((2R)-6-METHYLHEPTAN-2-YL)-2-PHENYL-2,5,10-TRIAZA-4-NOR-9.XI.-ESTR-7-ENE-1,3-DIONE
UNII V8JXN48CWQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 6.xi.-((3s,5r)-3,5-dihydroxy-2-methylcyclohex-1-en-1-yl)-17.beta.-((2r)-6-methylheptan-2-yl)-2-phenyl-2,5,10-triaza-4-nor-9.xi.-estr-7-ene-1,3-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V8JXN48CWQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C35H49N3O4 PTIHYNIKYFVMFI-UURGVQEHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6.xi.-((3s,5r)-3,5-dihydroxy-2-methylcyclohex-1-en-1-yl)-17.beta.-((2r)-6-methylheptan-2-yl)-2-phenyl-2,5,10-triaza-4-nor-9.xi.-estr-7-ene-1,3-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.